US2019282503A1PendingUtilityA1
Methods For Administering Weight Loss Medications
Assignee: NALPROPION PHARMACEUTICALS INCPriority: Nov 9, 2006Filed: May 31, 2019Published: Sep 19, 2019
Est. expiryNov 9, 2026(~0.3 yrs left)· nominal 20-yr term from priority
A61P 3/10A61P 3/06A61P 9/12A61P 43/00A61P 3/04A61P 3/00A61K 31/135A61K 9/20A61K 31/42A61J 1/035B65D 75/36A61K 31/137A61J 7/0454A61K 31/423A61K 9/48A61K 31/138A61K 31/35A61K 31/551A61K 45/06A61K 31/7048A61K 31/5513A61K 31/485A61K 9/209A61J 7/04
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and systems for administration of pharmaceuticals using a unit dosage package that includes a first unit dosage that has a first drug and a second drug, a second unit dosage that has the first drug and the second drug, where the second unit dosage includes a different amount of the second drug than the first unit dosage and a unit dosage package is configured to hold the first unit dosage and the second unit dosage. In preferred embodiments the methods and systems are used for administration of weight loss medications.
Claims
exact text as granted — not AI-modified1 . A unit dosage package for a pharmaceutical formulation, comprising:
a first unit dosage comprising a first drug and a second drug; a second unit dosage comprising said first drug and said second drug, wherein said second unit dosage comprises a different amount of said second drug than said first unit dosage; and a unit dosage package configured to hold said first unit dosage and said second unit dosage.
2 - 46 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.